Drugs and Medical Treatments: Fees and Charges
Commons · Question 25137 · Tabled 28 Aug 2026 · Department of Health and Social Care · Official record
Answered 7 Sep 2026
Question
Asked by Vikki Slade
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the MHRA-NICE aligned pathway that came into force on 1 April 2026 on the pricing of self-funded treatment and medications.
Answer
Answered by James Frith, 7 Sep 2026
The Government has not made any assessment of the impact of the aligned pathway on the pricing of self-funded treatments and medicines. The pathway aims to speed up access for National Health Service patients to clinically and cost-effective medicines by ...